M&A Deal Summary

Revance Therapeutics Acquires HintMD

On May 19, 2020, Revance Therapeutics acquired internet software and services company HintMD

Acquisition Highlights
  • This is Revance Therapeutics’ 1st transaction in the Internet Software and Services sector.
  • This is Revance Therapeutics’ 1st transaction in the United States.
  • This is Revance Therapeutics’ 1st transaction in California.

M&A Deal Summary

Date 2020-05-19
Target HintMD
Sector Internet Software and Services
Buyer(s) Revance Therapeutics
Deal Type Add-on Acquisition

Target

HintMD

Pleasanton, California, United States
HintMD is a private technology platform business working to revolutionize the aesthetic experience for physicians and patients. In addition to offering customized smart point-of-sale payment systems, the company partners with board-certified physicians to offer personalized treatment plan subscription solutions, loyalty programs, and integrated partners to drive patient engagement, compliance, and improved clinical outcomes. HintMD was formed in 2014 and is based in Pleasanton, California, supporting the needs of the U.S. medical aesthetic industry consisting of more than 33,000 physician-owned practices.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Revance Therapeutics

Newark, California, United States

Category Company
Founded 1999
Sector Life Science
Revenue 234M USD (2023)
DESCRIPTION

Revance Therapeutics is a specialty biopharmaceutical company focused on the development, manufacturing, and commercialization of novel botulinum toxin products for aesthetic and therapeutic categories. Revance Therapeutics was founded in 1999 and is based in Newark, California.


DEAL STATS #
Overall 1 of 1
Sector: Internet Software and Services M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2020 M&A 1 of 1